COVID-19 vaccination and antirheumatic therapy

The coronavirus disease 2019 (COVID-19) vaccination will be the largest vaccination programme in the history of the NHS. Patients on immunosuppressive therapy will be among the earliest to be vaccinated. Some evidence indicates immunosuppressive therapy inhibits humoral response to the influenza, pn...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Jack, Winthrop, Kevin, Emery, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989162/
https://www.ncbi.nlm.nih.gov/pubmed/33710296
http://dx.doi.org/10.1093/rheumatology/keab223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989162/
https://www.ncbi.nlm.nih.gov/pubmed/33710296
http://dx.doi.org/10.1093/rheumatology/keab223

Ejemplares similares